Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AILSE:MPAL -4.76% Earnings per Share (Diluted) is £-0.02 as of Feb. 2026. The stock has 1 warning sign investors should review. Among 503 Healthcare Providers & Services companies, MedPal AI ranks worse than 198806.96% on this metric.
MedPal AI's EPS (Basic) for the
six
months ended in Feb. 2026 was £-0.01.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2026 was £-0.02.
MedPal AI's EPS without NRI for the
six
months ended in Feb. 2026 was £-0.01.
Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2026 was £-0.01.
MedPal AI (LSE:MPAL) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
MedPal AI Earnings per Share (Diluted) Related Terms
MedPal AI Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for MedPal AI's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI Earnings per Share (Diluted) Chart
MedPal AI Annual Data
Trend
Aug22
Aug23
Aug24
Aug25
Earnings per Share (Diluted)
-0.00
0.00
0.00
-0.01
MedPal AI Semi-Annual Data
Feb24
Aug24
Feb25
Aug25
Feb26
Earnings per Share (Diluted)
0.00
0.00
-0.00
-0.01
-0.01
LSE:MPAL vs VEEV, BTSG, TEM: Earnings per Share (Diluted) Comparison
For the Health Information Services subindustry, MedPal AI's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedPal AI PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's PE Ratio distribution charts can be found below:
* The bar in red indicates where MedPal AI's PE Ratio falls into.
MedPal AI Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
MedPal AI's Earnings Per Share (Diluted) for the fiscal year that ended in Aug. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of £-0.02 mean?
MedPal AI (LSE:MPAL) has a Earnings per Share (Diluted) of £-0.02 as of Feb. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on MedPal AI and its competitors. According to the industry distribution chart, MedPal AI ranks #999999 out of 503 companies in the Healthcare Providers & Services industry.
Is MedPal AI's Earnings per Share (Diluted) too high?
MedPal AI's current Earnings per Share (Diluted) is £-0.02. Based on the distribution chart, MedPal AI ranks #999999 out of 503 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does MedPal AI's Earnings per Share (Diluted) compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #999999 out of 503 companies for Earnings per Share (Diluted). This places MedPal AI in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on MedPal AI and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current Earnings per Share (Diluted) is £-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Earnings per Share (Diluted) of £-0.02. The current Earnings per Share (Diluted) is £-0.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Earnings per Share (Diluted) is £-0.02 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MPAL has been successfully added to your 
